Autres langues NeuroPace, Inc.

Actions

NPCE

US6412881053

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
13,64 ^USD	-1,87%		+1,87%	+32,30%

14/03	NEUROPACE, INC. : Wells Fargo Securities relève à l'achat	ZM
12/03	NEUROPACE, INC. : JPMorgan Chase maintient sa recommandation à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024	17/04
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference	27/03
North American Morning Briefing : Inflation -2-	15/03
NeuroPace Shares Decline Following Q4 Financial Results	06/03
NeuroPace, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
NeuroPace, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Earnings Flash (NPCE) NEUROPACE Reports Q4 Revenue $18M, vs. Street Est of $17.7M	05/03
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million	05/03
NeuroPace, Inc. Provides Earnings Guidance for the Year 2024	05/03
NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024	15/02
NeuroPace, Inc Announces Resignation of Irina Ridley as Chief Legal Officer and Corporate Secretary	07/02
NeuroPace Preliminary Q4 Revenue Beats Street View; Shares Rise	08/01
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates	08/01
NeuroPace, Inc. Provides Preliminary Revenue Guidance for the Fourth Quarter Ended December 31, 2023	08/01
NeuroPace, Inc. Revises Revenue Guidance for the Full Year 2023	08/01
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study	21/12
NeuroPace, Inc. Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study	21/12
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference	19/12
NeuroPace to Leverage the Power of its RNS System's Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration	05/12
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration	04/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues NeuroPace, Inc.

Actions

NPCE

US6412881053

Autres langues

Filtres